期刊文献+

顺铂和卡铂致小鼠肝损害的实验研究

Study on the liver injuries induced by cisplatin and carboplatin in mice
原文传递
导出
摘要 目的探讨顺铂、卡铂致小鼠肝损害的时间及损伤机制。方法将90只小鼠分别尾静脉注射顺铂17mg/kg、卡铂67mg/kg及0.9%氯化钠注射液,分别于给药第3、7、11、14天测定各组小鼠血清生化指标、肝组织氧化及抗氧化指标,检查肝组织病理学改变。结果两实验组在给药第3天的病理切片即出现肝细胞脂肪变性,顺铂组尚有肝细胞点状坏死,周围有炎性细胞;两实验组天冬氨酸氨基转氨酶和碱性磷酸酶明显高于对照组(均P〈0.01),顺铂组丙氨酸氨基转氨酶明显高于对照组和卡铂组;两实验组氧化指标丙二醛明显高于对照组(均P〈0.01),抗氧化成分还原型谷胱甘肽明显低于对照组(均P〈0.01)。结论顺铂、卡铂在给药第3天即可引起肝组织损伤,顺铂致肝损伤的程度明显重于卡铂。 Objective To study the time the liver injuries appeared,the different level of liver injury induced by injecting Cisplatin and Carboplatin in mice and the possible mechanisms of the liver injury. Methods Mice were intravenously given, Cisplatin( 17 mg/kg), Carboplatin( 67 mg/kg) respectively. In the 3th ,7th, 11th and 14th day after injecting the medicines, the serum biochemistry parameters, oxidation and antioxidation parameters of liver and histopathologlc change in hepatic tissue were observed. Results HE stain showed that fatty degeneration of hepatocyte in the two experiment groups in the 3th day after injecting medicines, and hepatocellular spotty necrosis, and inflltration of inflammatory cells arroud the necrotic liver were found in, Cisplatin group. The level of aspartate aminotransferase and alkaline phosphatase in the two experiment groups increased significantly compared with those in the control (group P 〈 0.01 ) , and alanine aminotransferase in Cisplatin group increased significantly( P 〈 0.01 ) ,compared with that in the control group and Carboplatin group. Conclusion Hepatic injury was observed in the 3th day after injecting medicines ,the level of liver injury in Cisplatin group was heavier than that in Carboplatin group.
出处 《中国基层医药》 CAS 2010年第21期2915-2916,共2页 Chinese Journal of Primary Medicine and Pharmacy
基金 基金项目:广西壮族自治区卫生厅计划课题(Z2009170)
关键词 肝损害 顺铂 卡铂 Liver injury Cisplatin Carboplatin
  • 相关文献

参考文献10

二级参考文献40

  • 1杨平,初照成,王实,孙莉莉,周郦楠,张丽雁,张广新.顺铂对人卵巢癌CAOV_3细胞端粒酶活性和凋亡的影响[J].中国全科医学,2005,8(11):896-897. 被引量:7
  • 2王新峰,李磊,韩国柱.苦参素药理作用的研究进展[J].医药导报,2005,24(6):483-485. 被引量:53
  • 3钱建刚,马云宝,张晓懿.支气管肺炎患儿血清6种细胞因子测定[J].放射免疫学杂志,2005,18(5):333-335. 被引量:18
  • 4李勇,张湘茹,孙燕.非小细胞肺癌的化疗进展[J].癌症进展,2006,4(4):333-341. 被引量:40
  • 5[4]ww.fda.gov/cder/cancer/animalframe.htm
  • 6[5]FDA Guidance for industry and reviewers: Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers[ S]. 2002; 12
  • 7[6]FDA Guidance for Industry: food-effect bioavailability and fed bioequivalence studies[ S]. 2002; 12
  • 8Ma B,Yeo W,Hui P,et al Acute toxicity of adjuvant doxorubicin and cyclophosphamide for early breast cancer-a retrospective review of Chinese patients and comparison with an historic Western series [abstract][J].Radiother Oncol,2002,62(2): 185~1899
  • 9Honjo I,Suou T,Hirayama C.Hepatotoxicity of cyclophosphamide in mana: pharmacokinetic analysis [abstract][J].Res Commun Chen Pathol Pharmaclo,1998,61(2): 49
  • 10Sahashi M,Ono Y,Matsuura O.Combination chemotherapy for advanced urohelial-tract carcinoma [abstract][J].Cancer Chemother Pharmacol,1992,30 Suppl:59-62

共引文献1437

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部